Connection

Giordano Madeddu to Raltegravir Potassium

Back to Details
This is a "connection" page, showing publications Giordano Madeddu has written about Raltegravir Potassium.
Giordano Madeddu
Connection Strength
0.636
Raltegravir Potassium
  1. Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA =50 cp/mL. Infection. 2017 Aug; 45(4):521-528.
    View in: PubMed
    Score: 0.636
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.